140 related articles for article (PubMed ID: 14708557)
1. Pulmonary strongyloidiasis presenting as chronic bronchitis leading to interlobular septal fibrosis and cured by treatment.
Mukerjee CM; Carrick J; Walker JC; Woods RL
Respirology; 2003 Dec; 8(4):536-40. PubMed ID: 14708557
[TBL] [Abstract][Full Text] [Related]
2. Restrictive pulmonary disease due to interlobular septal fibrosis associated with disseminated infection by Strongyloides stercoralis.
Lin AL; Kessimian N; Benditt JO
Am J Respir Crit Care Med; 1995 Jan; 151(1):205-9. PubMed ID: 7812554
[TBL] [Abstract][Full Text] [Related]
3. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis.
Pornsuriyasak P; Niticharoenpong K; Sakapibunnan A
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):531-4. PubMed ID: 15689061
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole.
Nontasut P; Muennoo C; Sa-nguankiat S; Fongsri S; Vichit A
Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):442-4. PubMed ID: 15916052
[TBL] [Abstract][Full Text] [Related]
5. A case of fatal strongyloidiasis in a patient with chronic lymphocytic leukemia and molecular characterization of the isolate.
Kia EB; Rahimi HR; Mirhendi H; Nilforoushan MR; Talebi A; Zahabiun F; Kazemzadeh H; Meamar AR
Korean J Parasitol; 2008 Dec; 46(4):261-3. PubMed ID: 19127333
[TBL] [Abstract][Full Text] [Related]
6. Strongyloides as a cause of fever of unknown origin.
Neumann I; Ritter R; Mounsey A
J Am Board Fam Med; 2012; 25(3):390-3. PubMed ID: 22570402
[TBL] [Abstract][Full Text] [Related]
7. [An overview of Strongyloides stercoralis and its infections].
Ardiç N
Mikrobiyol Bul; 2009 Jan; 43(1):169-77. PubMed ID: 19334396
[TBL] [Abstract][Full Text] [Related]
8. Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy.
Page WA; Dempsey K; McCarthy JS
Trans R Soc Trop Med Hyg; 2006 Nov; 100(11):1056-62. PubMed ID: 16551471
[TBL] [Abstract][Full Text] [Related]
9. [Disseminated strongyloidiasis associated with pulmonary fibrosis and gastrointestinal bleeding].
Gloro R; Ollivier-Hourmand I; Morin-Fatome A; Rousselot P; Le Moel G; Dao T
Gastroenterol Clin Biol; 2004 Dec; 28(12):1287-90. PubMed ID: 15671941
[TBL] [Abstract][Full Text] [Related]
10. Diffuse alveolar haemorrhage and severe hypoxemia from Strongyloides stercoralis hyperinfection syndrome.
El-Sameed YA; Beejay N; Al Maashari R
Clin Respir J; 2015 Oct; 9(4):489-92. PubMed ID: 24902477
[TBL] [Abstract][Full Text] [Related]
11. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin.
Lichtenberger P; Rosa-Cunha I; Morris M; Nishida S; Akpinar E; Gaitan J; Tzakis A; Doblecki-Lewis S
Transpl Infect Dis; 2009 Apr; 11(2):137-42. PubMed ID: 19144097
[TBL] [Abstract][Full Text] [Related]
12. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children.
Marti H; Haji HJ; Savioli L; Chwaya HM; Mgeni AF; Ameir JS; Hatz C
Am J Trop Med Hyg; 1996 Nov; 55(5):477-81. PubMed ID: 8940976
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary strongyloidiasis].
Lozada H; Daza JE
Rev Chilena Infectol; 2016 Oct; 33(5):584-588. PubMed ID: 28112345
[TBL] [Abstract][Full Text] [Related]
14. Severe gastrointestinal strongyloidiasis.
Lambertucci JR; Westin MR; Barbosa AJ
Rev Soc Bras Med Trop; 2005; 38(4):365-6. PubMed ID: 16082494
[No Abstract] [Full Text] [Related]
15. Persistent eosinophilia and Strongyloides infection in Montagnard refugees after presumptive albendazole therapy.
Goswami ND; Shah JJ; Corey GR; Stout JE
Am J Trop Med Hyg; 2009 Aug; 81(2):302-4. PubMed ID: 19635888
[TBL] [Abstract][Full Text] [Related]
16. Management of Strongyloides stercoralis: a puzzling parasite.
Luvira V; Watthanakulpanich D; Pittisuttithum P
Int Health; 2014 Dec; 6(4):273-81. PubMed ID: 25173343
[TBL] [Abstract][Full Text] [Related]
17. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
[TBL] [Abstract][Full Text] [Related]
18. Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012.
Valerio L; Roure S; Fernández-Rivas G; Basile L; Martínez-Cuevas O; Ballesteros ÁL; Ramos X; Sabrià M;
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):465-70. PubMed ID: 23783760
[TBL] [Abstract][Full Text] [Related]
19. Infiltrating Strongyloides stercoralis presenting as duodenal obstruction.
Suvarna D; Mehta R; Sadasivan S; Raj VV; Balakrishnan V
Indian J Gastroenterol; 2005; 24(4):173-4. PubMed ID: 16204912
[TBL] [Abstract][Full Text] [Related]
20. Case Report: Ivermectin and Albendazole Plasma Concentrations in a Patient with Disseminated Strongyloidiasis on Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.
Boodman C; Chhonker YS; Murry DJ; Mah A; Grant J; Steiner T; Libman M; Nishi C; Charles M
Am J Trop Med Hyg; 2018 Nov; 99(5):1194-1197. PubMed ID: 30226142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
